Davydova Julia, Yamamoto Masato
Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Curr Protoc Hum Genet. 2013 Jul;Chapter 12:Unit 12.14. doi: 10.1002/0471142905.hg1214s78.
Oncolytic adenoviruses are designed to take advantage of the virus' native ability to replicate in cancer cells to induce oncolysis. Subsequently, the released viral progeny spread and kill the neighboring cancer cells. These characteristics, together with the ability of adenovirus to infect a broad spectrum of cells, its well understood replication machinery, and relative ease of manufacture have led to the intensive use of adenovirus as an anticancer agent. This unit describes cloning strategies, procedures to turn the intended design into virus, and quality analyses of resultant adenoviral vectors. Most of these procedures were optimized especially for oncolytic adenoviral vectors.
溶瘤腺病毒旨在利用病毒在癌细胞中复制以诱导溶瘤的天然能力。随后,释放的病毒后代扩散并杀死邻近的癌细胞。这些特性,连同腺病毒感染广泛细胞类型的能力、其广为人知的复制机制以及相对易于制造的特点,导致腺病毒被大量用作抗癌剂。本单元描述了克隆策略、将预期设计转化为病毒的程序以及所得腺病毒载体的质量分析。这些程序大多是专门针对溶瘤腺病毒载体进行优化的。